Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech vs. Shorts -- Ignore unavailable to you. Want to Upgrade?

To: rrufff who wrote (424)	5/27/2004 11:06:33 AM
From: keokalani'nui	Respond to of 427

Fascinating tale, rrufff. I paw no BTs on the list, but Dogs, International hounded throw interesting I think I'll lick 'em up.

To: rrufff who wrote (424)	5/28/2004 11:57:07 AM
From: Biomaven	Read Replies (1) \| Respond to of 427

I recognize one respectable biotech-related company on the list - Pharsight, now fallen on hard times and relegated to the BB. There are a couple of promotional-type nanocap biotechs on the list, but nothing that I have ever followed. (In general I stay far away from BB biotechs - biotech generally needs too much financial muscle for tiny companies to succeed - it's tough enough with $200m in the bank, let alone $2m). Mostly I suspect these stocks are depressed because their fundamentals are terrible, not because they are the victims of illegal shorting (although that of course might be the case as well). Peter